title: CE: Cardiotoxicity and Breast Cancer as Late Effects of Pediatric and Adolescent Hodgkin Lymphoma Treatment.
abstract: The American Cancer Society estimates that in 2014 nearly 16,000 U.S. children and adolescents developed cancer, and in roughly 1,200 of these cases the cancer was Hodgkin lymphoma (HL). The great majority of these patients will survive, joining the thousands who have been diagnosed and treated successfully in decades past. Nurses' familiarity with and attention to the late effects of the chemotherapy and radiation therapy used to treat HL, which include breast cancer as well as cardiotoxicity and its sequelae, are essential in helping these patients maintain their overall health.
authors.affiliation: Joanne Lee Candela is an adult NP in the survivorship program at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York City. Contact author: candelaj@mskcc.org. The author acknowledges Bridgette Thom, MS, research specialist at the MSKCC, for her thoughtful suggestions regarding the manuscript. The author and planners have disclosed no potential conflicts of interest, financial or otherwise.
authors.forename: Joanne Lee
authors.initials: JL
authors.lastname: Candela
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000209:etiology; D066126:Cardiotoxicity / Q000453:epidemiology*; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D014481:United States / Q000453:epidemiology